Asper Biotech is a genetic testing company, established in 1999 as a spin-off of a research organization called the Estonian Biocentre which employs scientists, professors and Ph.D.s. Since then Asper Biotech has quickly became a leading Estonian biotechnology exporter due to our extensive services and the quality of the results.
The company’s unique technology Arrayed Primer Extension (APEX) allows simultaneous, cost effective detection of hundreds DNA alterations in many different genes. In addition to APEX we offer testing by next generation sequencing, Sanger sequencing, MLPA analysis, and other technologies.
Asper Biotech started with three testing portfolios – Asper Ophthalmics, including a panel of tests targeting hereditary eye disorders; Asper Oncogenetics, providing tests to determine predisposition to various cancers; and Asper Reprogenetics, specializing in reproduction problems and prenatal diagnosis.
Now we have expanded our test menu to focus also on cardiological and neurological disorders, as well as hearing loss related disorders. New tests are assembled into Asper Cardiogenetics, Asper Neurogenetics, and Asper Otogenetics testing portfolios. Asper Wellness includes genetic tests for determining food intolerance, athletic performance, and also tests related to nutrition and other areas of wellness.
Asper Biotech’s laboratory is an authorized medical laboratory, CLIA (#99D2046227), ISO 15189:2008, and ISO 9001:2008 certified. Asper Biotech is participating in the European Molecular Genetics Quality Network (EMQN) quality assessment schemes in order to obtain the external quality control for mutation scanning and improve our testing services.
Asper Biotech serves clients, including leading university hospitals, private clinics, commercial laboratories and research organisations from more than 40 countries. Development and elaboration of new tests are continuous processes in our daily practice to meet the customers’ needs and provide testing services to more patients and healthcare providers. We are also offering custom-test development with complete workflow and full customer support.
Besides providing genetic diagnostic services, we are an appreciated scientific partner for many international R&D projects due to our innovation-driven approach and long-lasting experience. During the last 17 years, we have had successful collaboration with different funding agencies supporting R&D activities, which have led to technological improvements and moreover to state-of-the-art genetic tests. Our expertise is widely recognized by participation in numerous European-wide research projects where Asper Biotech has been incorporated as an essential partner.